468
Participants
Start Date
April 1, 2022
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
University of Pittsburgh, Pittsburgh
Geisinger Clinic, Danville
The Johns Hopkins University, Baltimore
The University of North Carolina at Chapel Hill, Chapel Hill
Duke University, Durham
The Ohio State University, Columbus
The Regents of the University of Michigan, Ann Arbor
State University of Iowa, Iowa City
The Medical College of Wisconsin, Inc., Milwaukee
Mayo Clinic, Rochester
University of Kansas Medical Center, Kansas City
Ochsner Clinic Foundation d/b/a Ochsner Health, New Orleans
The University of Texas Southwestern Medical Center, Dallas
University of Utah, Salt Lake City
Lead Sponsor
Collaborators (4)
Duke Clinical Research Institute
OTHER
Bristol-Myers Squibb
INDUSTRY
Exelixis
INDUSTRY
Merck Sharp & Dohme LLC
INDUSTRY
Pfizer
INDUSTRY
Duke University
OTHER